Related Experiment Videos

A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients

Olaf Burkhardt1, Jan T Kielstein

  • 1Department of Pulmonary Medicine, Medical School Hannover, Germany. burkhardt.olaf@mh-hannover.de

Expert Review of Anti-Infective Therapy
|December 18, 2009
PubMed

Insights

Dialysis patients face high risks for serious infections like methicillin-resistant Staphylococcus aureus (MRSA). A new daptomycin dosing schedule offers effective treatment for these vulnerable individuals.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Chronic renal replacement therapy affects 2.3 million worldwide, with infections causing significant morbidity and mortality.
  • Dialysis patients have a 100-fold higher risk of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections, accounting for 15% of all cases.
  • Existing treatments for Gram-positive infections in this population are limited.

Discussion:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a severe threat to patients on chronic renal replacement therapy.
  • Daptomycin offers a viable treatment option for complicated skin and soft tissue infections, vancomycin-resistant enterococcal infections, and right-sided endocarditis.
  • A simplified three-times weekly dosing regimen enhances practicality and adherence for hemodialysis patients.

Key Insights:

  • A simplified daptomycin regimen provides effective treatment for hemodialysis patients.
  • This approach addresses the heightened risk of invasive MRSA infections in the renal replacement therapy population.
  • Daptomycin's efficacy extends to various resistant Gram-positive infections.

Outlook:

  • Further research into optimizing antibiotic regimens for dialysis patients is warranted.
  • Exploring daptomycin's role in preventing infections within this high-risk group could be beneficial.
  • Improved treatment strategies are crucial for reducing mortality and morbidity in chronic renal replacement therapy patients.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...